Identifying food-effect risk before clinical studies
Food-dependent absorption can introduce significant variability in drug exposure, creating uncertainty in clinical performance and dosing strategy.
In this case study, molecular insights and pharmacokinetic modeling—supported by the OSDPredict™ platform—were used to clarify the mechanisms driving food effects early in development. This approach enabled the customer to make informed formulation and clinical strategy decisions, reducing uncertainty ahead of clinical studies.
Leveraging the OSDPredict™ platform, the team was able to: